NCT07130565View on ClinicalTrials.gov

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 1, 2028

Study Completion Date

November 1, 2028

Conditions
AmyloidCardiac AmyloidosisAmyloidosis
Interventions
DIAGNOSTIC_TEST

18F-92/AV45/TPZA/FT8, 11CPIB

Each subject receive a single intravenous injection of 18F-92/AV45/TPZA/FT8, 11C-PIB and undergo PET/CT or MRI imaging within the specificed time.

Trial Locations (2)

230000

RECRUITING

The First Affiliated Hospital of University of Science and Technology of China, Hefei

350005

RECRUITING

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Tianjin Medical University

OTHER